Ledger.Open graph →
SEC Form D · filed December 7, 2015

Perle Bioscience, Inc

Offering
$2.8M
Sold
$1.7M
Exemption
Rule 506(b)
Industry
Other
Location
CHARLESTON, SC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Jeffrey N. Riley · Charleston, SCDirectorDonna N. Hill · Charleston, SCDirectorGilbert N. Nathan · Charleston, SCDirectorRyan N. Fiorini · Charleston, SCExec · DirectorDouglas N. Carnes · Charleston, SCDirectorClaresa N. Levetan · Charleston, SCExec · DirectorAydin Babakhani · Katy, TXExec · DirectorOmar Kulbrandstad · Katy, TXExec · DirectorRobin Berzin · New York, NYDirectorRobert W. Fordi · ANNAPOLIS, MDDirectorC. M. Cox · Dallas, TXDirectorScott Bigham · Austin, TXDirectorSteven D. Scheiwe · SEATTLE, WADirectorTagar C. Olson · SEATTLE, WADirectorDiane B. Glossman · SEATTLE, WADirectorMichael L. Willingham · SEATTLE, WAExec · DirectorCharles E. Smith · SEATTLE, WAExec · DirectorMichael J. Renoff · SEATTLE, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗